The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
Bloomberg
Abbott Laboratories won US approval for its FreeStyle LibreLink diabetes-monitoring app, giving users a way to keep track of their glucose levels from their iPhones.
The app works with Abbott’s FreeStyle Libre glucose sensors, which have rapidly become some of the top-selling medical devices in the US. It is likely to be a welcome addition for millions of customers who currently rely on separate pocket-sized gadgets to read their results. Rivals Medtronic Plc and DexCom Inc. already had smartphone capability for their glucose systems. The approval of the app by the Food and Drug Administration was announced by Abbott.
In October, Abbott introduced alarms in Europe that let Libre users know when their glucose levels are too high or too low. FreeStyle LibreLink apps for Apple Inc.’s iPhone and Android devices have also been available in Europe since February 2018, with more than 250,000 downloads. Service for US Android devices is still under development.
The app, free to download in the App Store, enables users to instantly capture and view their real-time glucose levels, assess their eight-hour glucose history, and see a directional arrow indicating how their glucose is changing, according to the company.